A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea
- BNP and amino terminal proBNP assays did not differ for detecting congestive heart failure in the emergency department. Mueller, T.; Gegenhuber, A.; Poelz, W.; Doust, Jenny // Evidence Based Medicine;Oct2005, Vol. 10 Issue 5, p148
The article discusses how do B type natriuretic peptide (BNP) concentrations compare with amino terminal proBNP concentrations for detecting congestive heart failure (CHF) in emergency department (ED). The study was conducted in 251 ED patients who had shortness of breath as the most prominent...
- Nesiritide: A Review of its Use in Acute Decompensated Heart Failure. Keating, G.M.; Goa, K.L. // Drugs;2003, Vol. 63 Issue 1, p47
Nesiritide (Natrecor) is a recombinant form of human B-type (brain) natriuretic peptide that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is administered intravenously for the management of patients with decompensated congestive heart failure (CHF). In...
- BACH: MRproANP, MRproADM plus BNP improved acute HF diagnoses. // Cardiology Today;Jun2010, Vol. 13 Issue 6, p22
The article focuses on a study about the impact of combining midregional pro-atrial natriuretic peptide with B-type natriuretic peptide on the diagnosis of acute heart failure (HF) which was published in an issue of the "Journal of the American College of Cardiology."
- BATTLESCARRED: NT-proBNP-guided therapy improved mortality in older patients with chronic HF. // Cardiology Today;Feb2010, Vol. 13 Issue 2, p23
The article discusses the BATTLESCARRED research on the efficacy of a hormone-guided treatment strategy guided by N-terminal pro-B-type natriuretic peptide levels in reducing mortality in patients aged 75 years and older with chronic heart failure (HF), with a reference to a study by J....
- Natriuretic peptides associated with adiponectin production in HF. Raible, Eric // Cardiology Today;Jul2009, Vol. 12 Issue 7, p20
The article discusses a study on the association between natriuretic peptides and the production of adiponectin, a protein, in patients with congestive heart failure (HF).
- BNP levels had high sensitivity but moderate specificity for detecting congestive heart failure in the emergency department. Lader, Ellis // ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p23
Focuses on a study which examined the diagnostic properties of B-type natriuretic peptide levels for detecting congestive heart failure. Assessment of the clinical characteristics of patients; Description of test and diagnostic standard; Outcome measures.
- Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Sato, Y.; Taniguchi, R.; Makiyama, T.; Nagai, K.; Okada, H.; Yamada, T.; Matsumori, A.; Takatsu, Y. // Heart;Dec2002, Vol. 88 Issue 6, p647
Examines the significance of troponin and brain natriuretic peptide (BNP) concentrations in patients with congestive heart failure (CHF). Selection of patient information presenting with decompensated CHF and pulmonary congestion; Increase of baseline plasma concentrations of BNP; Expression of...
- Plasma proatrial natriuretic factor in patients with CHF. // American Family Physician;3/1/1996, Vol. 53 Issue 4, p1373
Reports on a study published in the 1995 issue of the `American Journal of Cardiology' periodical by Dickstein and associates who investigated the relationship between the concentration of pro-atrial natriuretic factor (proANF) and clinical status in patients with congestive heart failure. ...
- BNP testing 'could help patients with unstable angina'. // GP: General Practitioner;6/23/2003, p7
B-type natriuretic peptide (BNP) testing could benefit patients with unstable angina and MI, as well as those with heart failure, according to Great Britain researchers. NICE is expected to back the introduction of BNP testing as a way of identifying which heart failure patients need to undergo...